Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder
Condition:   Binge-Eating Disorder Interventions:   Drug: ACT-539313;   Drug: Placebo Sponsor:   Idorsia Pharmaceuticals Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2021 Category: Research Source Type: clinical trials

The Role of the Circadian System in Binge Eating Disorder
Conditions:   Binge-Eating Disorder;   Circadian Rhythm Disorders Interventions:   Dietary Supplement: Melatonin (3hrs before DLMO);   Dietary Supplement: Placebo (3hrs before DLMO);   Device: Morning light version 1;   Device: Morning light version 2 Sponsors:   University of Cincinnati;   National Institute of Mental Health (NIMH);   Lindner Center of HOPE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2021 Category: Research Source Type: clinical trials

The Role of the Circadian System in Binge Eating Disorder
Conditions:   Binge-Eating Disorder;   Circadian Rhythm Disorders Interventions:   Dietary Supplement: Melatonin (3hrs before DLMO);   Dietary Supplement: Placebo (3hrs before DLMO);   Device: Morning light version 1;   Device: Morning light version 2 Sponsors:   University of Cincinnati;   National Institute of Mental Health (NIMH);   Lindner Center of HOPE Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 26, 2021 Category: Research Source Type: clinical trials

Examining Self-tracking Behaviors in a Mobile Intervention for Binge Eating and Weight Management
Conditions:   Obesity;   Binge Eating Interventions:   Behavioral: Track clinician-determined symptoms;   Behavioral: Track clinician-determined and self-determined symptoms Sponsor:   Northwestern University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 15, 2021 Category: Research Source Type: clinical trials